At present, several drug molecules have been used for the treatment of rheumatoid arthritis
(RA). However, the utilization of these compounds through the oral and parenteral route is …

Rheumatoid arthritis (RA) is a systemic autoimmune disease characterized by chronic joint
inflammation which ultimately leads to severe disability and premature mortality. It has a …

Rheumatoid arthritis (RA) is an autoimmune disease involving joints, with clinical
manifestations of joint inflammation, bone damage and cartilage destruction, joint …

Rheumatoid arthritis (RA) is one of the common and severe autoimmune diseases related to
joints. This chronic autoimmune inflammatory disease, leads to functional limitation and …

Rheumatoid arthritis (RA) is an autoimmune disorder that affects the joints. Various
medications successfully alleviate the symptoms of RA in clinical. Still, few therapy strategies …

Rheumatoid arthritis (RA) is an autoimmune disease accompanies with synovial
inflammation and progressive bone destruction. Currently, anti-rheumatic drugs need high …

Rheumatoid arthritis is a severe autoimmune disorder, related to joints. It is associated with
serious cartilage destruction. This causes disability and reduces the excellence of life …

The combination of pharmaceutical technologies can be a wise choice for developing
innovative therapeutic strategies. The association of nanocarriers and gels provides new …

Background This study aims to evaluate the influence of nanoparticle size on the in vitro
percutaneous penetration and retention and in vivo anti-inflammatory efficacy of …

Purpose In the clinical setting, raloxifene, a second-generation selective estrogen receptor
modulator, is administered orally; however, the bioavailability (BA) is only 2% because of its …